Wegovy Outperforms Zepbound and Tirzepatide in Reducing Heart Risks
A real-world study shows that Novo Nordisk's Wegovy significantly outperforms Eli Lilly's Zepbound, reducing serious heart issues like stroke by over 50%.
Tag
Heart Diseases
All articles tagged with #heart diseases
Johnson & Johnson's $13 Billion Acquisition of Shockwave Medical Energizes Heart Device Business
Johnson & Johnson has agreed to acquire Shockwave Medical for $12.5 billion, expanding its portfolio of medical devices for treating heart diseases. The acquisition provides J&J access to Shockwave's device that uses shockwaves to break down calcified plaque in heart vessels, with the total addressable market for similar therapies estimated at about $10 billion. This move follows J&J's previous acquisitions to strengthen its cardiac health division, and the company expects to finance the deal through a combination of cash on hand and debt.
Johnson & Johnson's $13.1 Billion Shockwave Medical Acquisition Strengthens MedTech Business
Johnson & Johnson has agreed to acquire Shockwave Medical for $12.5 billion, expanding its portfolio of medical devices for treating heart diseases. The deal gives J&J access to Shockwave's catheter-based treatment using shockwaves to break down calcified plaque in heart vessels, complementing its focus on building its cardiac health business. This acquisition follows J&J's previous purchases in the heart device sector and is expected to close by mid-2024, financed through a combination of cash and debt.
The Growing Connection: COVID's Impact on Heart Health, Long-Term Effects, and Mental Well-being
Mounting evidence suggests a definite link between Covid-19 infection and a range of heart diseases, even among those who had a mild case and recovered well. Research shows that for up to a year after a Covid infection, individuals are at an increased risk of developing heart-related problems such as irregular heartbeats, spikes in blood pressure, blood clots, and heart attacks. Studies have found that those who had mild Covid had stiffer and more dysfunctional arteries, which are precursors to cardiovascular disease. Additionally, recent research indicates that Sars-CoV-2 can directly affect blood vessels, increasing the risk of heart attacks and strokes. The findings highlight the importance of Covid vaccines in reducing the inflammatory effects of the virus and protecting against long-term heart complications.
Unveiling the Intricate Cartography of the Human Heart
Scientists have created the most detailed cell catalogue of the human heart to date, mapping eight regions and profiling 75 different cell states. Using single-cell transcriptomics methods, researchers analyzed over 700,000 individual cells and nuclei from tissue samples of 25 donor hearts. The study revealed the presence of glial cells supporting signaling processes in pacemaker cells, immune cells producing antibodies to protect the heart from infections, and a population of cells in the myocardium that are sensitive to stress and inflammation. The findings could lead to new ways to improve heart treatments and further research into heart diseases.
Cancer and Heart Disease Vaccines Expected by 2030.
New vaccines aimed at curing cancer, heart diseases, and autoimmune diseases could potentially save millions of lives around the world. Ongoing studies have been offering promising results, with efforts that previously took 15 years now being shortened to 12-18 months due to the COVID-19 vaccines. Companies like Moderna and Pfizer are developing mRNA-based vaccines that could be highly effective and save many lives. However, experts warn that without sufficient funding, all the efforts of years would be wasted.